All News

Nanotechnology is in its infancy, but will revolutionize how we develop and deliver drugs in the near future.

News briefs for hospital pharmacists

Aside from workflow and technology issues, pharmacists and physicians participating in pilot projects onder the Medicare Modernization Act generally supported e-prescribing.

Until problems with Baxter heparin are resolved, APP Pharmaceuticals has been working hard to ensure that there are no gaps in supply to hospial and dialysis units.

John Lemberger gives his point of view about a failure to counsel citation from the Wisconsin Board of Pharmacy

Brief descriptions of over-the-counter, home health, brand, and generic drug

Google is testing its new open electronic health records systems, Google Health at the Cleveland Clinic.

This article highlights new over-the-counter products for eye health including eye drops and eye washes.

This article is contributed by the Hamacher Resource Group (www.hamacher.com). Based in Milwaukee and with offices in the United Kingdom, HRG's comprehensive services combine the art of communicating with the science of data analysis to improve the profitability of every link in the retail healthcare supply chain. Manufacturers, retailers, wholesalers, and others count on HRG for strategic solutions to their business goals.

The National Governors Association will recommend that a cross-state cooperative pharmacist licensure system be created so that pharmacists can practice across state/territorial lines.

Drug Topics profiles Schnucks Pharmacy, chain of the year for 2008

What are the current prescribing trends and controversial issues that impact pediatric therapeutic management?

Pharmacies fight back after pressure from the Drug Enforcement Administration has forced Cardinal Healthcare and other wholesaler drug distributors to implement systems to stop drug diversion

States issue guidelines for the April 1st implementation of Medicare's tamper-resistant prescription pad rule

Because of cardiovascular and gastrointestinal risks, NSAIDS are no longer recommended for long-term use. No single drug or therapy is regarded as the ideal long-term treatment for osteoarthritis.

Wyeth will begin marketing its new serotonin-norepinephrine reuptake inhibitor.

Thirteen percent of all eligible prescriptions are transmitted electronically in Massachusetts.

Students need grounding in chemistry

Here is a listing of brand pharmaceuticals that will lose their patents through 2009.

Cubist Pharmaceuticals finds impurity in reconstituted daptomycin

Pfizer revises package insert after reports of lung cancer in patients receiving their inhaled insulin.

DEA is proposing to consider ANPP as a precursor to fentanyl and to classify it as a Schedule II controlled substance.

The FDA and Institute for Safe Medication Practices report that many drug errors are still occurring with Cerebyx because many hospital staffers are misreading the drug concentration.

Walter Jones has received the endorsement from the National Community Pharmacists Association in his primary battle for the rural North Carolina House district.

Rite Aid is partnering with MedStar Health and Consumer Health Services to launch in-store clinics in select Rite Aid stores.

HospiScript Services, a provider of pharmacy medication therapy management services to hospices has been acquired by HealthExtras

The Midwest wholesaler McQueary Brothers has agreed to be acquired by McKesson Corp.for $190 million.

Novartis is set to pay as much as $39 biliion to buy a controlling stake in Alcon, a Houston company that dominates the eye care market.